Pandrug-resistant Acinetobacter baumannii causing nosocomial infections in a University Hospital, Taiwan

Emerging Infectious Diseases

Volumn 8, Issue 8, 2002, Pages 827-832

  Hsueh, Po Ren ^a   Teng, Lee Jene ^a   Chen, Cheng Yi ^a   Chen, Wen Hwei ^a   Yu, Chong Jen ^a   Ho, Shen Wu ^a   Luh, Kwen Tay ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; ANTIBIOTIC AGENT; AZTREONAM; CARBAPENEM DERIVATIVE; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; FLOMOXEF; GENTAMICIN; IMIPENEM; MEROPENEM; MOXIFLOXACIN; NETILMICIN; PIPERACILLIN PLUS TAZOBACTAM; SULTAMICILLIN; TOBRAMYCIN; TROVAFLOXACIN;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; DRUG POTENTIATION; GENOTYPE; HOSPITAL INFECTION; HUMAN; INTENSIVE CARE UNIT; NONHUMAN; POLYMERASE CHAIN REACTION; PULSED FIELD GEL ELECTROPHORESIS; RANDOM AMPLIFIED POLYMORPHIC DNA; TAIWAN; UNIVERSITY HOSPITAL; VIRUS ISOLATION;

EID: 0036686040     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid0805.020014     Document Type: Article

References (26)

1. National Nosocomial Infections Surveillance (NNIS) System report, data summary from January 1990-May 1999, issued in 1999
2. Surveillance of antimicrobial use and antimicrobial resistance in United States hospital: Project ICARE phase 2
3. Multi-center surveillance of antimicrobial resistance of major bacterial pathogens in intensive care units in 2000 in Taiwan
4. Emergence of antimicrobial drug resistance of major pathogens causing nosocomial infections at a university hospital in Taiwan, 1981-1999
5. Current status of antimicrobial resistance in Taiwan
6. Clinical and molecular epidemiology of Acinetobacter infections sensitive only to polymyxin B and sulbactam
7. Worldwide emergence of carbapenem-resistant Acinetobacter spp
8. Persistence of a multidrug-resistant Pseudomonas aeruginosa clone in an intensive care burn unit
9. Antimicrobial susceptibility among clinical isolates of extended-spectrum cephalosporin-resistant gram-negative bacteria in A Taiwanese university hospital
10. Metallo-βlactamases among clinical isolates of Pseudomonas in Taiwan and identification of VIM-3, a novel variant of the VIM-2 enzyme
11. Emergence and rapid spread of carbapenem resistance furing a large and sustained hospital outbreak of multiresistant Acinetobacter baumannii
12. Bacteremia due to Acinetobacter baumannii: Epidemiology, clinical findings, and prognostic features
13. MYSTIC (Meropenem Yearly Susceptibility Test Information Collection) results from the Americas: Resistance implications in the treatment of serious infections
14. Carbapenem resistance mediated by beta-lactamases in clinical isolates of Acinetobacter baumannii
15. Emergence of carbapenem-hydrolyzing enzymes in Acinetobacter baumannii clinical isolates
16. Characterization of a hospital outbreak of imipenem-resistant Acinetobacter baumannii by phenotypic and genotypic typing methods
17. Characterization of a nosocomial outbreak caused by multiresistant Acinetobacter baumannii strain with a carbapenem-hydrolyzing enzyme: High-level carbapenem resistance in A. baumannii is not due solely to the presence of β-lactamases
18. CDC definition for nosocomial infections, 1988
19. Activities of levofloxacin, ofloxacin, and ciprofloxacin, alone and in combination with amikacin, against Acinetobacters as determined by the checkerboard and time-kill studies
20. Comparative in vitro antimicrobial susceptibilities of nosocomial isolates of Acinetobacter baumannii and synergistic activities of nine antimicrobial combinations
21. Comparison of methodologies for synergism testing of drug combinations against resistant strains of Pseudomonas aeruginosa
22. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: Criteria for bacterial strain typing
23. In vitro activities of ampicillin-sulbactam and amoxicillin-clavulanic acid against Acinetobacter baumannii
24. Imipenem resistance among Acinetobacter baumannii: Association with reduced expression of a 33-36 kDa outer membrane protein
25. Significance of antimicrobial synergism for the outcome of gram-negative sepsis